Teleflex to Present at the 6th European Conference of Interventional Oncology (ECIO)

WAYNE, Pa.--()--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase a wide array of products for minimally invasive interventional applications at the 6th European Conference of Interventional Oncology (ECIO) in Nice, France, on April 22-25, 2015.

This portfolio includes the Arrow® OnControl® Powered Bone Access System.

Teleflex will present a wide array of technologically advanced products for minimally invasive interventional applications from its Arrow® product line that are designed to enhance performance in interventional access and peripheral vascular procedures. These include peripherally inserted catheters, highly kink-resistant sheath introducers and a broad technology platform that is defining the field of intraosseous (inside the bone) medicine.

Current applications include vascular access, emergency and disaster medicine, oncology and spinal surgery.

Key product of focus will be the Arrow® OnControl® Power Driver and the Arrow® OnControl® Bone Lesion Biopsy Tray. Using patented technology, this device provides interventional radiologists and oncologists a faster, more reliable solution for accessing dense and hard-to-reach bone lesions. The Arrow® OnControl® Bone Lesion Biopsy Tray contains all the instruments needed for multiple, high-quality bone lesion biopsies, from a single cortical penetration.

Teleflex aims to offer patients and physicians the latest treatment options to save procedure steps, time and costs, in order to help enhance clinician efficiency and patient care.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 11,700 people and serves healthcare providers worldwide. For additional information about Teleflex please refer to www.teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, Arrow and OnControl are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. ©2015 Teleflex Incorporated. All rights reserved.

Contacts

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com
or
Martina Teichmann-Zindler
Director Marketing Communications International
+49 (0)7151-406-538
martina.teichmann@teleflex.com
www.teleflex.com

Release Summary

Teleflex to Present at the 6th European Conference of Interventional Oncology (ECIO)

Contacts

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com
or
Martina Teichmann-Zindler
Director Marketing Communications International
+49 (0)7151-406-538
martina.teichmann@teleflex.com
www.teleflex.com